A Study of miRNA 371 in Patients With Germ Cell Tumors
This study is investigating a specific blood marker, called micro ribonucleic acid (miRNA) 371, in patients who have been diagnosed with germ cell tumours, including those affecting the testicles. The main goal is to find out if checking the levels of this marker in blood samples can help doctors predict whether the cancer is likely to come back after treatment. By studying these blood samples in the laboratory, researchers hope to gain a better understanding of how germ cell tumours behave. This could lead to improved ways of monitoring patients and making more informed decisions about their care in the future. The study involves collecting blood samples regularly from patients over a few years.
At a glance
What is this study about?
This study is trying to understand more about germ cell tumours. These are a type of cancer that can appear in different parts of the body, though they most commonly affect the testicles in men. When someone is diagnosed with a germ cell tumour, doctors want to know the best way to monitor them afterwards and if there's a chance the cancer might come back. This research focuses on a tiny substance in the blood called micro ribonucleic acid (miRNA) 371. The idea is to see if measuring this particular substance in a patient's blood can give doctors clues about whether the cancer is likely to return.
Imagine your body is like a complex machine, and miRNA 371 is a small signal that might indicate something important is happening. Researchers believe that if they can accurately read this signal, it could help them predict the risk of the cancer coming back. This information would be really valuable because it could allow doctors to tailor follow-up plans better for each patient. For example, if the marker suggests a higher risk, doctors might monitor that patient more closely.
Ultimately, the hope is that by figuring out more about miRNA 371, we can improve how doctors care for people with germ cell tumours. It's about finding better ways to keep an eye on things and potentially spot any problems early, leading to better outcomes for patients. This study doesn't test new treatments, but rather tries to find a better way to predict how the cancer might behave.
Key takeaways
- This study investigates a blood marker (miRNA 371) in germ cell tumour patients.
- The goal is to predict if your cancer might return.
- It involves regular blood tests over up to 3 years.
- No new treatments are given; it's for research and understanding the illness.
- Your normal medical care will continue unaffected.
- You must be 18 or older and recently diagnosed with a germ cell tumour.
Who may be eligible?
To join this study, you must have been recently diagnosed with a germ cell tumour. This diagnosis needs to be confirmed either by looking at tissue samples under a microscope or by certain blood tests showing high levels of specific markers. All types of germ cell tumours, no matter where they are in the body or how advanced they are, can be considered.
If you're a male patient with early-stage testicular cancer and surgery (called an orchiectomy) is planned, this surgery must have happened no more than 42 days before you enrol in the study. Importantly, you need to sign up for the study within 42 days of your diagnosis and before you start any main treatment or management plan for your cancer. You also need to have had your initial scans and blood tests within the 42 days before joining.
Finally, you must be 18 years old or older. You'll need to agree to provide blood samples for the study and be willing to give your permission for these samples to be used for future research. This involves signing a consent form to show you understand and agree to take part.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Have I been recently diagnosed with a germ cell tumour?
- Am I 18 years old or older?
- Can I provide regular blood samples for up to 3 years?
- Am I willing for my samples to be used for future research?
- Have I not yet started my main treatment for the cancer?
- If I had testicular cancer surgery, was it less than 42 days ago?
What does participation involve?
If you decide to take part in this study, the main thing you'll need to do is provide blood samples regularly. These blood samples will be taken every 3 to 6 months. This will continue for up to 3 years. These collections will often happen at the same time as your usual blood tests for monitoring your cancer (like beta-HCG, AFP, and LDH), so it shouldn't require many extra visits.
Doctors will also collect information about your health, such as details from your scans and pathology reports. You'll be asked to provide consent for your samples to be used for current and future research. There are no new medications or treatments involved in this study; it's purely about collecting information and samples to understand germ cell tumours better.
Potential risks and benefits
Locations (424)
- Banner MD Anderson Cancer CenterVerified postcodeGilbert, United States
- Kingman Regional Medical CenterVerified postcodeKingman, United States
- University of Arizona Cancer Center-Orange Grove CampusVerified postcodeTucson, United States
- Banner University Medical Center - TucsonVerified postcodeTucson, United States
- University of Arizona Cancer Center-North CampusVerified postcodeTucson, United States
- Mercy Hospital Fort SmithVerified postcodeFort Smith, United States
- Kaiser Permanente-AnaheimVerified postcodeAnaheim, United States
- Kaiser Permanente-Deer Valley Medical CenterVerified postcodeAntioch, United States
- PCR OncologyVerified postcodeArroyo Grande, United States
- Kaiser Permanente-Baldwin ParkVerified postcodeBaldwin Park, United States
- Kaiser Permanente-BellflowerVerified postcodeBellflower, United States
- Keck Medicine of USC Buena ParkVerified postcodeBuena Park, United States
Common questions
What is a germ cell tumour?
A germ cell tumour is a type of cancer that starts in cells that are meant to develop into sperm or eggs, but can sometimes appear in other parts of the body, most commonly the testicles in men.
What is miRNA 371?
miRNA 371 is a tiny molecule found in your blood. In this study, researchers are looking to see if levels of this molecule can help predict if a germ cell tumour might return.
Will this study give me new treatment?
No, this study is about understanding the disease better, not about testing new treatments. You will continue to receive your standard medical care as advised by your doctor.
How long will I be in the study?
You'll be asked to provide blood samples every 3-6 months for up to 3 years.
Will taking part affect my regular medical care?
No, taking part in this study will not affect the medical care you receive for your germ cell tumour. You can also withdraw at any time.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.